The Director, New Product Commercialization is responsible for commercial input into lifecycle strategy, business development, as well as product and portfolio assessments across small-molecules, gene therapies, peptides and antibodies in one of four therapeutic areas: Neurology, Neuroimmunology, Neuroendocrinology or Psychiatry. Responsibilities include active participation in early commercial planning and market research for Neurocrine's therapeutic candidates from early-stage pre-clinical development through early phase three. Key workstreams include market opportunity assessments, patient journey and lifecycle prioritization for current and potential pipeline programs with emphasis on disease area understanding, competitive landscapes, unmet medical need, reimbursement environment and overall commercial attractiveness. This individual will lead commercial insights for development programs across stage gates in the drug development process.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
1,001-5,000 employees